Fractures clinical trials

Explore recruiting fractures clinical trials.

Recruiting fractures studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Fractures trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Efficacy of nasal oxygen therapy on the reduction of postoperative complications in ankle trauma surgery in at-risk patients: a randomized pilot study

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

An Open-label, Randomized, Active-Controlled, Phase 3 Study of Setrusumab Compared With Bisphosphonates in Pediatric Subjects With Osteogenesis Imperfecta Types I, III or IV

Netherlands, Germany, Italy, Poland, France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Treatment of Osteogenesis Imperfecta with Parathyroid hormone and Zoledronic acid

France, Ireland, Netherlands, Denmark

Therapeutic use (Phase IV) EU CTIS Study details

Strategies for zoledronic acid post-denosumab discontinuation in postmenopausal osteoporosis

France

Therapeutic use (Phase IV) EU CTIS Study details

A Phase 3, Open-Label, Multicenter, Randomized Study to evaluate the Efficacy and Safety of Romosozumab Compared with Bisphophonates in Children and Adolecents with Osteogenesis Imperfecta

Slovakia, Germany, Belgium, Spain, Hungary, Austria +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Prospective, randomized, multicentre study to compare the efficacy at 52 weeks (1 year) of biosimilar teriparatide and alendronate in the prevention of new morphometric vertebral fractures and/or worsening of previous vertebral fractures in women with a clinical vertebral fracture or recent hip fracture (imminent risk of fracture) caused by bone fragility.

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Fractures trials by city

Fractures in Toronto Fractures in Vancouver Fractures in Montreal Fractures in Calgary Fractures in Edmonton Fractures in Ottawa Fractures in Winnipeg Fractures in Quebec City Fractures in Hamilton Fractures in Kitchener Fractures in London Fractures in Halifax Fractures in New York Fractures in Los Angeles Fractures in Chicago Fractures in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease